KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Equity (2016 - 2025)

Historic Return on Equity for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to 0.22%.

  • Vertex Pharmaceuticals' Return on Equity rose 2500.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.23% for FY2025, which is 2600.0% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Return on Equity is 0.22%, which was up 2500.0% from 0.21% recorded in Q3 2025.
  • Vertex Pharmaceuticals' 5-year Return on Equity high stood at 0.31% for Q1 2021, and its period low was 0.06% during Q1 2025.
  • For the 5-year period, Vertex Pharmaceuticals' Return on Equity averaged around 0.18%, with its median value being 0.22% (2024).
  • Over the last 5 years, Vertex Pharmaceuticals' Return on Equity had its largest YoY gain of 2500bps in 2025, and its largest YoY loss of -2800bps in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Return on Equity stood at 0.24% in 2021, then grew by 3bps to 0.25% in 2022, then dropped by -14bps to 0.21% in 2023, then plummeted by -116bps to 0.03% in 2024, then surged by 757bps to 0.22% in 2025.
  • Its Return on Equity was 0.22% in Q4 2025, compared to 0.21% in Q3 2025 and 0.22% in Q2 2025.